Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by ME Therapeutics Holdings Inc.

News headline image
ME Therapeutics Extends Option Agreement for CD22 Nanobody Asset
From ME Therapeutics Holdings Inc.
Via Business Wire
Tickers CSE:METX
News headline image
ME Therapeutics to Pitch at CSE Capital Tech Connect During Web Summit Vancouver
From ME Therapeutics Holdings Inc.
Via Business Wire
Tickers CSE:METX
News headline image
ME Therapeutics Provides Scientific Update on In Vivo CAR and Therapeutic mRNA Programs
From ME Therapeutics Holdings Inc.
Via Business Wire
Tickers CSE:METX
News headline image
ME Therapeutics Scientific and Corporate Update
From ME Therapeutics Holdings Inc.
Via Business Wire
Tickers CSE:METX
News headline image
ME Therapeutics Attending JP Morgan Healthcare Conference
From ME Therapeutics Holdings Inc.
Via Business Wire
Tickers CSE:METX
News headline image
ME Therapeutics Granted Licence for CD22 Nanobody Asset to Expand Next-Gen In Vivo CAR Cell Therapy Program
From ME Therapeutics Holdings Inc.
Via Business Wire
Tickers CSE:METX
News headline image
ME Therapeutics Added to CSE25 Index
From ME Therapeutics Holdings Inc.
Via Business Wire
Tickers CSE:METX
News headline image
ME Therapeutics Secures U.S. Patent for Lead Candidate and Advances Broader Therapeutic Programs
From ME Therapeutics Holdings Inc.
Via Business Wire
Tickers CSE:METX
News headline image
ME Therapeutics Receives Support to Advance mRNA Therapeutic Candidates for Cancer and Inflammatory Disease
From ME Therapeutics Holdings Inc.
Via Business Wire
Tickers CSE:METX
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.